Report Analyzes Pipeline Drugs with Potential to Impact Canada’s Future Drug Spending
The latest edition of the Patented Medicine Prices Review Board (PMPRB) Meds Pipeline Monitor reports that oncology continued to dominate the
Report Analyzes Pipeline Drugs with Potential to Impact Canada’s Future Drug Spending
